FibroBiologics Says IP Australia Issues Notice Of Acceptance For Australian Patent Application Titled ‘Cellular Blend For The Regeneration Of Chondrocytes Or Cartilage Type Cells’

FibroBiologics, Inc. announced that IP Australia has issued a Notice of Acceptance for its Australian Patent Application No. 2024200985, which covers methods for regenerating cartilage using a combination of fibroblasts, platelet-rich plasma, and nucleus pulposus conditioned media. The company, which is focused on developing therapeutics for chronic diseases, holds over 270 patents issued and pending. This patent acceptance may enhance its position in the biotechnology sector.